Loading organizations...
Targeted therapeutics and delivery systems for gastrointestinal diseases.
RDD Pharma has raised $9.5M across 1 funding round.
RDD Pharma has raised $9.5M in total across 1 funding round.
RDD Pharma has raised $9.5M in total across 1 funding round.
RDD Pharma's investors include Capital Point, OrbiMed, Pharmascience.
RDD Pharma has raised $9.5M across 1 funding round. Most recently, it raised $9.5M Series B in November 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 16, 2017 | $9.5M Series B | Capital Point, OrbiMed, Pharmascience |